Srushti Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 0.68 M
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.08 Cr
- Revenue Growth 164.83%
- Profit Growth 177.78%
- Ebitda 1894.30%
- Net Worth 34.62%
- Total Assets 6.46%
About Srushti Pharmaceuticals
Srushti Pharmaceuticals Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 November 1985 and has a history of 39 years and three months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.68 M.
The company has closed loans amounting to ₹3.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jatish Sheth and Mayuri Sheth serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230KA1985PTC007272
- Company No.
007272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Srushti Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatish Sheth  | Director | 08-Nov-1985 | Current |
| Mayuri Sheth | Director | 12-May-2014 | Current |
Financial Performance of Srushti Pharmaceuticals.
Srushti Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 164.83% increase. The company also saw a substantial improvement in profitability, with a 177.78% increase in profit. The company's net worth Soared by an impressive increase of 34.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srushti Pharmaceuticals?
Unlock access to Srushti Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bal Pharma LimitedJatish Sheth is a mutual person
Meganza Pharma LlpJatish Sheth and Mayuri Sheth are mutual person
Charges (Loans)
₹0
₹30.80 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2008 | State Bank Of India | ₹3.08 Cr | Satisfied |
How Many Employees Work at Srushti Pharmaceuticals?
Srushti Pharmaceuticals has a workforce of 13 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srushti Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srushti Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
